Home › Companies › Cartesian Therapeutics, Inc. › 2025-2026
At Cartesian Therapeutics, Inc.'s shareholder meeting held June 12, 2026, in the 2025-2026 proxy season, 94 asset managers reported how they voted on 5 ballot items in their SEC Form N-PX filings, covering 562 separate fund positions. On the most widely held item on that ballot — To approve, on a non-binding and advisory basis, a resolution approving the compensation of… — Cartesian Therapeutics, Inc.'s filing reports the proposal as approved, with 99.0% support of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side). Source: Cartesian Therapeutics, Inc.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on June 17, 2026.
Download data (CSV): ballot items · votes by manager · column guide.
Compiled from SEC Form N-PX filings and Cartesian Therapeutics, Inc.’s Form 8-K, filed June 17, 2026 (Item 5.07 on EDGAR). Page generated November 8, 2026.
Meeting of June 12, 2026: 5 items on Cartesian Therapeutics, Inc.’s Form 8-K, filed June 17, 2026: 3 elected · 2 approved.
Material dissent: a director nominee under 80% of the votes cast, say-on-pay under 70%, any other item the board put forward under 80%, or a shareholder proposal with more than 50%, on the company’s own Form 8-K tally. How this is decided
Explore Cartesian Therapeutics, Inc. in the interactive database Compare manager voting policies
These tallies are Cartesian Therapeutics, Inc.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed June 17, 2026 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Support (of votes cast) | Reported outcome | Voting standard |
|---|---|---|---|---|---|---|---|---|
| Elect Director: Michael Singer, M.D., Ph.D. | 11,745,619 | -- | -- | 8,083,506 | 4,322,411 | 59% | Elected | — |
| Elect Director: Timothy A. Springer, Ph.D. | 18,665,163 | -- | -- | 1,163,962 | 4,322,411 | 94% | Elected | — |
| Elect Director: Patrick Zenner, M.B.A | 12,168,919 | -- | -- | 7,660,206 | 4,322,411 | 61% | Elected | — |
| 2. Approval, on a non-binding and advisory basis, of a resolution approving the compensation of the Company's named executive officers | 13,659,709 | 136,217 | 6,033,199 | -- | 4,322,411 | 99.0% | Approved | — |
| 3. Ratification of the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the year ending December 31, 2026 | 24,144,742 | 6,157 | 637 | -- | -- | 99.9% | Approved | — |
Source: Cartesian Therapeutics, Inc., Form 8-K, filed with the SEC on June 17, 2026 — read the filing on EDGAR.
Each item below shows how the 94 asset managers that disclosed a Cartesian Therapeutics, Inc. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report.
Combines 6 wordings of this item as funds reported it.
59% Majority: yes · of votes cast
Description as filed by funds: Election of Directors: Michael Singer, M.D., Ph.D.
Cartesian Therapeutics, Inc.’s own tally for this item (“Elect Director: Michael Singer, M.D., Ph.D.”): 11,745,619 for, 8,083,506 withheld, per its Form 8-K filed June 17, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “Based on the votes set forth above, each director nominee was duly elected to serve until the Company's 2029 Annual Meeting of Stockholders, and until their respective successors have been duly elected and qualified.”
Support: 59% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 36 asset managers below reported 1,305,890 for, 65,747 withheld, 893 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 808,786 | 0 | 0 | 0 | For |
| Vanguard | 237,459 | 0 | 1 | 0 | For |
| BlackRock | 199,113 | 0 | 0 | 0 | For |
| BRIDGEWAY FUNDS INC | 0 | 0 | 0 | 25,000 | Withhold |
| QUANTITATIVE MASTER SERIES LLC | 16,062 | 0 | 0 | 0 | For |
| Equitable | 6,070 | 0 | 0 | 8,328 | Mixed |
| Columbia Threadneedle | 11,816 | 0 | 0 | 0 | For |
| CLEARWATER INVESTMENT TRUST | 0 | 0 | 0 | 9,239 | Withhold |
| Nationwide | 839 | 0 | 0 | 8,165 | Mixed |
| Lincoln Financial | 7,126 | 0 | 0 | 0 | For |
| Global X | 5,295 | 0 | 0 | 0 | For |
| PACE SELECT ADVISORS TRUST | 0 | 0 | 0 | 4,526 | Withhold |
| AIG/SunAmerica | 0 | 0 | 0 | 4,059 | Withhold |
| Bridge Builder Trust | 4,005 | 0 | 0 | 0 | For |
| Pacific Life | 3,066 | 0 | 0 | 0 | For |
| DWS | 0 | 0 | 0 | 1,600 | Withhold |
| ProShares | 0 | 0 | 0 | 1,558 | Withhold |
| Northern Trust | 1,400 | 0 | 0 | 0 | For |
| Goldman Sachs | 1,350 | 0 | 0 | 0 | For |
| Charles Schwab | 1,289 | 0 | 0 | 0 | For |
| Victory Capital | 0 | 0 | 0 | 1,147 | Withhold |
| Voya | 1,026 | 0 | 0 | 0 | For |
| Venerable Variable Insurance Trust | 0 | 0 | 0 | 767 | Withhold |
| Calvert | 0 | 0 | 0 | 708 | Withhold |
| John Hancock | 0 | 0 | 692 | 0 | Abstain |
Showing the 25 largest of 36 asset managers. All 36 are in the interactive database (link above).
Combines 5 wordings of this item as funds reported it.
61% Majority: yes · of votes cast
Description as filed by funds: Election of Directors: Patrick Zenner, MBA
Cartesian Therapeutics, Inc.’s own tally for this item (“Elect Director: Patrick Zenner, M.B.A”): 12,168,919 for, 7,660,206 withheld, per its Form 8-K filed June 17, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “Based on the votes set forth above, each director nominee was duly elected to serve until the Company's 2029 Annual Meeting of Stockholders, and until their respective successors have been duly elected and qualified.”
Support: 61% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 36 asset managers below reported 1,276,292 for, 95,345 withheld, 893 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 808,786 | 0 | 0 | 0 | For |
| Vanguard | 237,001 | 0 | 1 | 458 | For |
| BlackRock | 199,113 | 0 | 0 | 0 | For |
| BRIDGEWAY FUNDS INC | 0 | 0 | 0 | 25,000 | Withhold |
| QUANTITATIVE MASTER SERIES LLC | 16,062 | 0 | 0 | 0 | For |
| Equitable | 6,070 | 0 | 0 | 8,328 | Mixed |
| Columbia Threadneedle | 0 | 0 | 0 | 11,816 | Withhold |
| CLEARWATER INVESTMENT TRUST | 0 | 0 | 0 | 9,239 | Withhold |
| Nationwide | 839 | 0 | 0 | 8,165 | Mixed |
| Lincoln Financial | 0 | 0 | 0 | 7,126 | Withhold |
| Global X | 0 | 0 | 0 | 5,295 | Withhold |
| PACE SELECT ADVISORS TRUST | 0 | 0 | 0 | 4,526 | Withhold |
| AIG/SunAmerica | 0 | 0 | 0 | 4,059 | Withhold |
| Bridge Builder Trust | 4,005 | 0 | 0 | 0 | For |
| Pacific Life | 3,066 | 0 | 0 | 0 | For |
| DWS | 0 | 0 | 0 | 1,600 | Withhold |
| ProShares | 0 | 0 | 0 | 1,558 | Withhold |
| Northern Trust | 0 | 0 | 0 | 1,400 | Withhold |
| Goldman Sachs | 1,350 | 0 | 0 | 0 | For |
| Charles Schwab | 0 | 0 | 0 | 1,289 | Withhold |
| Victory Capital | 0 | 0 | 0 | 1,147 | Withhold |
| Voya | 0 | 0 | 0 | 1,026 | Withhold |
| Venerable Variable Insurance Trust | 0 | 0 | 0 | 767 | Withhold |
| Calvert | 0 | 0 | 0 | 708 | Withhold |
| John Hancock | 0 | 0 | 692 | 0 | Abstain |
Showing the 25 largest of 36 asset managers. All 36 are in the interactive database (link above).
Combines 6 wordings of this item as funds reported it.
94% Majority: yes · of votes cast
Description as filed by funds: Election of Directors: Timothy A. Springer, Ph.D.
Cartesian Therapeutics, Inc.’s own tally for this item (“Elect Director: Timothy A. Springer, Ph.D.”): 18,665,163 for, 1,163,962 withheld, per its Form 8-K filed June 17, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “Based on the votes set forth above, each director nominee was duly elected to serve until the Company's 2029 Annual Meeting of Stockholders, and until their respective successors have been duly elected and qualified.”
Support: 94% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 36 asset managers below reported 724,088 for, 647,547 withheld, 894 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 227,593 | 0 | 0 | 581,193 | Mixed |
| Vanguard | 237,148 | 0 | 2 | 309 | For |
| BlackRock | 199,113 | 0 | 0 | 0 | For |
| BRIDGEWAY FUNDS INC | 0 | 0 | 0 | 25,000 | Withhold |
| QUANTITATIVE MASTER SERIES LLC | 16,062 | 0 | 0 | 0 | For |
| Equitable | 6,070 | 0 | 0 | 8,328 | Mixed |
| Columbia Threadneedle | 11,816 | 0 | 0 | 0 | For |
| CLEARWATER INVESTMENT TRUST | 0 | 0 | 0 | 9,239 | Withhold |
| Nationwide | 839 | 0 | 0 | 8,165 | Mixed |
| Lincoln Financial | 7,126 | 0 | 0 | 0 | For |
| Global X | 5,295 | 0 | 0 | 0 | For |
| PACE SELECT ADVISORS TRUST | 0 | 0 | 0 | 4,526 | Withhold |
| AIG/SunAmerica | 0 | 0 | 0 | 4,059 | Withhold |
| Bridge Builder Trust | 4,005 | 0 | 0 | 0 | For |
| Pacific Life | 3,066 | 0 | 0 | 0 | For |
| DWS | 0 | 0 | 0 | 1,600 | Withhold |
| ProShares | 0 | 0 | 0 | 1,558 | Withhold |
| Northern Trust | 1,400 | 0 | 0 | 0 | For |
| Goldman Sachs | 1,350 | 0 | 0 | 0 | For |
| Charles Schwab | 1,289 | 0 | 0 | 0 | For |
| Victory Capital | 0 | 0 | 0 | 1,147 | Withhold |
| Voya | 1,026 | 0 | 0 | 0 | For |
| Venerable Variable Insurance Trust | 0 | 0 | 0 | 767 | Withhold |
| Calvert | 0 | 0 | 0 | 708 | Withhold |
| John Hancock | 0 | 0 | 692 | 0 | Abstain |
Showing the 25 largest of 36 asset managers. All 36 are in the interactive database (link above).
Combines 8 wordings of this item as funds reported it.
99.0% Approved · of votes cast
Description as filed by funds: To approve, on a non-binding and advisory basis, a resolution approving the compensation of Cartesian Therapeutics, Inc.'s named executive officers, as described in the accompanying proxy statement under "Executive and Director Compensation."
Cartesian Therapeutics, Inc.’s own tally for this item (“2. Approval, on a non-binding and advisory basis, of a resolution approving the compensation of the Company's named executive officers”): 13,659,709 for, 136,217 against — passed, per its Form 8-K filed June 17, 2026 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “Based on the votes set forth above, the stockholders approved, on a non-binding and advisory basis, a resolution approving the compensation of our named executive officers.”
Support: 99.0% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 808,786 | 0 | 0 | 0 | For |
| Vanguard | 237,460 | 0 | 0 | 0 | For |
| BlackRock | 199,113 | 0 | 0 | 0 | For |
| BRIDGEWAY FUNDS INC | 0 | 25,000 | 0 | 0 | Against |
| QUANTITATIVE MASTER SERIES LLC | 16,062 | 0 | 0 | 0 | For |
| Equitable | 14,398 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 11,816 | 0 | 0 | 0 | For |
| CLEARWATER INVESTMENT TRUST | 9,239 | 0 | 0 | 0 | For |
| Nationwide | 9,004 | 0 | 0 | 0 | For |
| Lincoln Financial | 7,126 | 0 | 0 | 0 | For |
| Global X | 5,295 | 0 | 0 | 0 | For |
| PACE SELECT ADVISORS TRUST | 4,526 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 4,059 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 4,005 | 0 | 0 | 0 | For |
| Pacific Life | 3,066 | 0 | 0 | 0 | For |
| DWS | 1,600 | 0 | 0 | 0 | For |
| ProShares | 1,558 | 0 | 0 | 0 | For |
| Northern Trust | 1,400 | 0 | 0 | 0 | For |
| Goldman Sachs | 1,350 | 0 | 0 | 0 | For |
| Charles Schwab | 1,289 | 0 | 0 | 0 | For |
| Victory Capital | 1,147 | 0 | 0 | 0 | For |
| Voya | 1,026 | 0 | 0 | 0 | For |
| Venerable Variable Insurance Trust | 767 | 0 | 0 | 0 | For |
| Calvert | 708 | 0 | 0 | 0 | For |
| John Hancock | 692 | 0 | 0 | 0 | For |
Fund voting reports, all 36 managers: 1,347,330 for, 25,200 against. Showing the 25 largest; every one is in the interactive database (link above).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 613,385 | 0 | 0 | 0 | For |
| 683 Capital Management, LLC | 320,975 | 0 | 0 | 0 | For |
| GEODE CAPITAL MANAGEMENT, LLC | 265,259 | 0 | 0 | 0 | For |
| State Street | 158,111 | 0 | 0 | 0 | For |
| BlackRock | 78,462 | 32 | 0 | 0 | For |
| Citadel | 66,032 | 0 | 0 | 0 | For |
| Northern Trust | 39,040 | 0 | 0 | 0 | For |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 31,770 | 0 | 0 | 0 | For |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 0 | 25,000 | 0 | 0 | Against |
| AQR | 22,458 | 0 | 0 | 0 | For |
| MELLON INVESTMENTS Corp | 18,488 | 0 | 0 | 0 | For |
| Vanguard | 14,198 | 0 | 0 | 0 | For |
| Nuveen | 13,012 | 0 | 0 | 0 | For |
| ACADIAN ASSET MANAGEMENT LLC | 12,803 | 0 | 0 | 0 | For |
| AllianceBernstein | 12,765 | 0 | 0 | 0 | For |
| Two Sigma | 12,532 | 0 | 0 | 0 | For |
| Point72 | 9,446 | 0 | 0 | 0 | For |
| UBS | 0 | 9,193 | 0 | 0 | Against |
| MARSHALL WACE, LLP | 8,449 | 0 | 0 | 0 | For |
| T. Rowe Price | 5,914 | 0 | 0 | 0 | For |
| Goldman Sachs | 5,783 | 0 | 0 | 0 | For |
| JPMorgan | 4,263 | 0 | 0 | 0 | For |
| ZACKS INVESTMENT MANAGEMENT | 4,135 | 0 | 0 | 0 | For |
| NEW YORK STATE COMMON RETIREMENT FUND | 3,902 | 0 | 0 | 0 | For |
| PNC BANK, NATIONAL ASSOCIATION | 3,369 | 0 | 0 | 0 | For |
Institutional-manager reports, all 70 managers: 1,747,749 for, 37,823 against, 1,000 abstained. Showing the 25 largest; every one is in the interactive database (link above).
Combines 2 wordings of this item as funds reported it.
99.9% Approved · of votes cast
Description as filed by funds: TO RATIFY THE APPOINTMENT OF ERNST & YOUNG LLP AS CARTESIAN THERAPEUTICS, INC.'S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 31, 2026.
Cartesian Therapeutics, Inc.’s own tally for this item (“3. Ratification of the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the year ending December 31, 2026”): 24,144,742 for, 6,157 against — passed, per its Form 8-K filed June 17, 2026 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “Based on the votes set forth above, the stockholders ratified the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the year ending December 31, 2026.”
Support: 99.9% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 36 asset managers below reported 1,372,530 for.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 808,786 | 0 | 0 | 0 | For |
| Vanguard | 237,460 | 0 | 0 | 0 | For |
| BlackRock | 199,113 | 0 | 0 | 0 | For |
| BRIDGEWAY FUNDS INC | 25,000 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 16,062 | 0 | 0 | 0 | For |
| Equitable | 14,398 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 11,816 | 0 | 0 | 0 | For |
| CLEARWATER INVESTMENT TRUST | 9,239 | 0 | 0 | 0 | For |
| Nationwide | 9,004 | 0 | 0 | 0 | For |
| Lincoln Financial | 7,126 | 0 | 0 | 0 | For |
| Global X | 5,295 | 0 | 0 | 0 | For |
| PACE SELECT ADVISORS TRUST | 4,526 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 4,059 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 4,005 | 0 | 0 | 0 | For |
| Pacific Life | 3,066 | 0 | 0 | 0 | For |
| DWS | 1,600 | 0 | 0 | 0 | For |
| ProShares | 1,558 | 0 | 0 | 0 | For |
| Northern Trust | 1,400 | 0 | 0 | 0 | For |
| Goldman Sachs | 1,350 | 0 | 0 | 0 | For |
| Charles Schwab | 1,289 | 0 | 0 | 0 | For |
| Victory Capital | 1,147 | 0 | 0 | 0 | For |
| Voya | 1,026 | 0 | 0 | 0 | For |
| Venerable Variable Insurance Trust | 767 | 0 | 0 | 0 | For |
| Calvert | 708 | 0 | 0 | 0 | For |
| John Hancock | 692 | 0 | 0 | 0 | For |
Showing the 25 largest of 36 asset managers. All 36 are in the interactive database (link above).
Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 29,381,514 shares outstanding at the time of that meeting.
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Fidelity | 2.75% |
| 2 | Vanguard | 0.81% |
| 3 | BlackRock | 0.68% |
| 4 | BRIDGEWAY FUNDS INC | 0.09% |
| 5 | QUANTITATIVE MASTER SERIES LLC | 0.05% |
| 6 | Equitable | 0.05% |
| 7 | Columbia Threadneedle | 0.04% |
| 8 | CLEARWATER INVESTMENT TRUST | 0.03% |
| 9 | Nationwide | 0.03% |
| 10 | Lincoln Financial | 0.02% |
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Fidelity | 2.09% |
| 2 | 683 Capital Management, LLC | 1.09% |
| 3 | GEODE CAPITAL MANAGEMENT, LLC | 0.90% |
| 4 | State Street | 0.54% |
| 5 | BlackRock | 0.27% |
| 6 | Citadel | 0.22% |
| 7 | Northern Trust | 0.13% |
| 8 | JACOBS LEVY EQUITY MANAGEMENT, INC | 0.11% |
| 9 | BRIDGEWAY CAPITAL MANAGEMENT, LLC | 0.09% |
| 10 | AQR | 0.08% |
As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row names its form.
| Holder | % outstanding | Disclosure |
|---|---|---|
| Entities affiliated with Timothy A. Springer, Ph.D. | — | DEF14A |
| Timothy A. Springer, Ph.D. | — | DEF14A |
| Entities affiliated with Murat Kalayoglu, M.D., Ph.D. | — | DEF14A |
| Murat Kalayoglu | — | 13D |
| Entities affiliated with Squarepoint Capital | — | DEF14A |
| Squarepoint Ops LLC | — | 13G |
| Barclays PLC | — | 13G |
| JPMORGAN CHASE & CO. | — | 13G |
| FMR (Fidelity) | — | 13F |
| FMR LLC | — | 13G |
Percentages above are of 29,381,514 shares outstanding, as reported by Cartesian Therapeutics, Inc. on its Form 10-Q dated April 23, 2026 (see the filing on EDGAR). This is the count contemporaneous with the 2025-2026 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from Cartesian Therapeutics, Inc.’s 10-Q dated April 23, 2026. This page is a static snapshot rebuilt weekly on November 8, 2026; a live search always shows the current data.
Cartesian Therapeutics, Inc. proxy season coverage: 2023-2024 · 2024-2025 · 2025-2026 (this page).
proxyvotesnow.com, “Cartesian Therapeutics (RNAC) 2026 Annual Meeting: Vote Results”, https://proxyvotesnow.com/company/cartesian-therapeutics-inc/2026 (version of November 8, 2026). Derived from SEC Form N-PX and Form 8-K filings; tables licensed CC BY 4.0. Licence: CC BY 4.0.